Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study
- PMID: 12133023
- DOI: 10.1046/j.1532-5415.2002.50315.x
Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study
Abstract
Objectives: To determine specific physiological correlates of the geriatric syndrome of frailty that warrant further investigation.
Design: Population-based case-control study.
Setting: General Clinical Research Center at Johns Hopkins Bayview Medical Center.
Participants: Community-dwelling adults aged 74 and older from Baltimore, Maryland.
Measurements: Frailty status was determined using a recently validated screening tool that consists of weight loss, fatigue, low levels of physical activity, and measurements of grip strength and walking speed. Serum interleukin-6 (IL-6) was measured using enzyme-linked immunosorbent assay, and standard complete blood count was performed using a Coulter counter.
Results: Eleven frail and 19 nonfrail subjects with mean age +/- standard deviation of 84.9 +/- 6.7 vs 81.3 +/- 4.1 years, respectively, completed the study. The frail subjects had significantly higher serum IL-6 levels and significantly lower hemoglobin and hematocrit than the nonfrail subjects (4.4 +/-2.9 vs 2.8 +/- 1.6 pg/mL, 12.1 +/- 1.1 vs 13.9 +/- 1.0 g/dL, and 35.8% +/- 3.1% vs 40.6% +/- 2.8%, respectively). No significant difference was observed in mean corpuscular volume, red blood cell distribution width, or white blood cell and platelet counts between the frail and nonfrail groups. Furthermore, there was an inverse correlation between serum IL-6 level and hemoglobin (Pearson's correlation coefficient: -0.46) and hematocrit (-0.48) in the frail group but not in the nonfrail group.
Conclusion: These results suggest that frail subjects have evidence of inflammation and lower hemoglobin and hematocrit levels. This subclinical anemia is normocytic and is hence unlikely due to myelosuppression or iron deficiency and is potentially related to the increased chronic inflammatory state marked by serum IL-6 elevation. Further studies are indicated to better characterize the immune and hematological changes that underlie frailty.
Similar articles
-
Understanding red blood cell parameters in the context of the frailty phenotype: interpretations of the FIBRA (Frailty in Brazilian Seniors) study.Arch Gerontol Geriatr. 2014 Nov-Dec;59(3):636-41. doi: 10.1016/j.archger.2014.07.014. Epub 2014 Aug 14. Arch Gerontol Geriatr. 2014. PMID: 25236441
-
T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults.J Am Geriatr Soc. 2008 May;56(5):904-8. doi: 10.1111/j.1532-5415.2008.01673.x. Epub 2008 Apr 1. J Am Geriatr Soc. 2008. PMID: 18384587 Free PMC article.
-
Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women.J Am Geriatr Soc. 2005 May;53(5):747-54. doi: 10.1111/j.1532-5415.2005.53250.x. J Am Geriatr Soc. 2005. PMID: 15877548
-
Association between inflammatory markers and frailty in institutionalized older men.Maturitas. 2014 Nov;79(3):329-33. doi: 10.1016/j.maturitas.2014.07.014. Epub 2014 Jul 30. Maturitas. 2014. PMID: 25132319
-
Inflammatory Pathways to Anemia in the Frail Elderly.Clin Geriatr Med. 2019 Aug;35(3):339-348. doi: 10.1016/j.cger.2019.03.005. Epub 2019 May 9. Clin Geriatr Med. 2019. PMID: 31230735 Review.
Cited by
-
Frailty, inflammation, and immunity.Aging Dis. 2011 Dec;2(6):466-73. Epub 2011 Dec 2. Aging Dis. 2011. PMID: 22396895 Free PMC article.
-
Correlation between levels of TNF-alpha and IL-6 and hematological involvement in SLE Egyptian patients with lupus nephritis.Int Urol Nephrol. 2006;38(3-4):731-7. doi: 10.1007/s11255-006-0047-9. Epub 2007 Jan 27. Int Urol Nephrol. 2006. PMID: 17260180
-
The Impact of Frailty and Comorbidities on Heart Failure Outcomes.Card Fail Rev. 2022 Mar 21;8:e07. doi: 10.15420/cfr.2021.29. eCollection 2022 Jan. Card Fail Rev. 2022. PMID: 35399550 Free PMC article. Review.
-
The Role of Inflammatory and Cytokine Biomarkers in the Pathogenesis of Frailty Syndrome.Endocr Metab Immune Disord Drug Targets. 2022;22(14):1357-1366. doi: 10.2174/1871530322666220304220522. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35249513 Review.
-
Anemia and the risk of non-vertebral fractures: the Tromsø Study.Osteoporos Int. 2010 Oct;21(10):1761-8. doi: 10.1007/s00198-009-1131-7. Epub 2009 Dec 3. Osteoporos Int. 2010. PMID: 19957163
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources